Health
Judd Moul, MD, Reviews Studies From 2021 ASCO Showing Systemic Therapy Advancements in Prostate Cancer – Cancer Network
Judd Moul, MD, discusses the gravity of new data on systemic therapies for men with castration-resistant prostate cancer and…
Both trials demonstrated benefit of the experimental therapy in their respective patient cohorts, helping prolong overall survival versus standard-of-care regimens.
In an interview with CancerNetwork®, Judd Moul, MD, discussed these findings from the meeting…
Continue Reading
-
General14 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business13 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General15 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General16 hours agoAlbanese beats drum on economy as trade clouds gather